Logo-ps
Pharm Sci. 2020;26(Covid-19): S80-S81. doi: 10.34172/PS.2020.53

Commentary

Dexmedetomidine: An All Sedation-in–One Drug in Critically Ill Patients with COVID-19

Ata Mahmoodpoor 1, Elyad Ekrami 2, Hassan Soleimanpour 3 * ORCID

Cited by CrossRef: 2


1- Zhuang X, Fu L, Luo L, Dong Z, Jiang Y, Zhao J, Yang X, Hei F. The effect of perioperative dexmedetomidine on postoperative delirium in adult patients undergoing cardiac surgery with cardiopulmonary bypass: a systematic review and meta-analysis of randomized controlled trials. BMC Anesthesiol. 2024;24(1) [Crossref]
2- Tahsini Tekantapeh S, Ghojazadeh M, Ghamari A, Mohammadi A, Soleimanpour H. Therapeutic and anti-inflammatory effects of baricitinib on mortality, ICU transfer, clinical improvement, and CRS-related laboratory parameters of hospitalized patients with moderate to severe COVID-19 pneumonia: a systematic review and meta-analysis. Expert Review of Respiratory Medicine. 2022;16(10):1109 [Crossref]